Mouse IFN-β(Interferon Beta) ELISA Kit
中文名称：小鼠β干扰素(IFN-β)酶联免疫吸附测定试剂盒
Price:
- 反应性： Mouse
- 检测范围： 15.63-1000 pg/mL
- 灵敏度： 9.38 pg/mL
| 产品应用 | ELISA |
| 检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗小鼠IFN-β抗体包被于酶标板上，实验时样品（或标准品）中的小鼠IFN-β会与包被抗体结合。后依次加入生物素化的抗小鼠IFN-β抗体和辣根过氧化物酶标记的亲和素，抗小鼠IFN-β抗体与结合在包被抗体上的小鼠IFN-β结合，生物素与亲和素特异性结合而形成免疫复合物，游离的成分被洗去。加入显色底物(TMB)，TMB在辣根过氧化物酶的催化下呈现蓝色，加终止液后变成黄色。用酶标仪在450 nm波长处测OD值，IFN-β浓度与OD450值之间呈正比，通过绘制标准曲线计算出样品中IFN-β的浓度。 |
| 反应类型 | Sandwich-ELISA |
| 规格 |
96 T
/ 48 T
/ 96 T × 5
|
| 反应时间 | 3 h 30 min |
| 反应性 | Mouse |
| 检测方法 | 比色法;ELISA;夹心法 |
| 检测范围 | 15.63-1000 pg/mL |
| 灵敏度 | 9.38 pg/mL |
| 样本体积 | 100 μL |
| 样本类型 | 血清、血浆或其他生物体液 |
| 特异性 | 可检测样本中的小鼠IFN-β，且与其它类似物无明显交叉反应 |
| 精密度 | 板内，板间变异系数均<10% |
| 回收率 | 80%-120% |
| 储存条件 | 2-8℃ |
| 有效期 | 12个月 |
| 数据处理 |
-
Peptide nanotube loaded with a STING agonist, c-di-GMP, enhance cancer immunotherapy against melanoma
IF: 10.269 -
Structural characterization of a soluble polysaccharide SSPS1 from soy whey and its immunoregulatory activity in macrophages
IF: 8.025 -
Antitumor efficacy of a recombinant EGFR-targeted fusion protein conjugate that induces telomere shortening and telomerase downregulation
IF: 8.025Journal： INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)PMID：36435475Reactivity：MouseSample Type：serum -
Discovery of fusidic acid derivatives as novel STING inhibitors for treatment of sepsis
IF: 7.088 -
Design and synthesis of hederagenin derivatives modulating STING/NF-κB signaling for the relief of acute liver injury in septic mice
IF: 7.088 -
The selective STING inhibitor H-151 preserves myocardial function and ameliorates cardiac fibrosis in murine myocardial infarction
IF: 5.714 -
Menthone inhibits type-I interferon signaling by promoting Tyk2 ubiquitination to relieve local inflammation of rheumatoid arthritis
IF: 5.714 -
Activation of the STING-IRF3 pathway involved in psoriasis with diabetes mellitus
IF: 5.295Journal： JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)PMID：35174638Reactivity：MouseSample Type：serum -
NLRP3 inflammasome up-regulates major histocompatibility complex class I expression and promotes inflammatory infiltration in polymyositis
IF: 3.594 -
Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapy
IF: 8.947
实验操作视频
